Filing Details
- Accession Number:
- 0001562180-19-003105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-24 18:24:56
- Reporting Period:
- 2019-05-23
- Accepted Time:
- 2019-05-24 18:24:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597553 | Sage Therapeutics Inc. | SAGE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1042021 | M Jeffrey Jonas | C/O Sage Therapeutics, Inc. 215 First Street Cambridge MA 02142 | President & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-23 | 53,908 | $0.45 | 116,023 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-23 | 500 | $171.01 | 115,523 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-23 | 1,619 | $172.20 | 113,904 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-23 | 4,200 | $173.41 | 109,704 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-23 | 31,099 | $174.46 | 78,605 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-23 | 14,727 | $175.09 | 63,878 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-23 | 1,763 | $176.15 | 62,115 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 40,356 | $0.45 | 102,471 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-24 | 7,948 | $174.05 | 94,523 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-24 | 24,966 | $175.02 | 69,557 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-24 | 3,974 | $175.79 | 65,583 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-24 | 2,518 | $176.80 | 63,065 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-05-24 | 950 | $177.76 | 62,115 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-23 | 53,908 | $0.00 | 53,908 | $0.45 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-05-24 | 40,356 | $0.00 | 40,356 | $0.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 168,079 | 2023-08-12 | No | 4 | M | Direct | |
| 127,723 | 2023-08-12 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $175.45 USD to $176.42 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $176.46 USD to $177.39 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $177.47 USD to $178.16 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on August 12, 2017.
- This transaction was executed in multiple trades at prices ranging from $170.66 USD to $171.15 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $171.69 USD to $172.60 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $172.79 USD to $173.7872 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $173.79 USD to $174.78 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $174.81 USD to $175.80 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $175.89 USD to $176.80 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $173.43 USD to $174.42 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $174.45 USD to $175.43 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
